-
Sector Analysis
NewNew Drug Approvals and Their Contract Manufacture – 2024 Edition
This report is the 14th edition of our long-running analysis of the CMO industry, using the FDA's NDA approvals as the primary indicator of performance. New Drug Approvals and Their Contract Manufacture (formerly called "CMO Scorecard") is critical for benchmarking the performance of the contract manufacturing organization (CMO) industry and the relative performance of major CMOs. This year's edition includes a discussion of how inflation and increasing global conflict has impacted pharma manufacturers.
-
Product Insights
Likelihood of Approval Analysis for Idiopathic Inflammatory Myopathy (IIM)
Overview How likely is it that the drugs in Idiopathic Inflammatory Myopathy (IIM) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Idiopathic Inflammatory Myopathy (IIM) Overview Inflammation of muscle is known...
-
Sector Analysis
NewRadiosurgery Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Radiosurgery Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 is built to visualize quantitative market trends within Neurology Devices therapeutic area. The model discusses in detail the impact of COVID-19 on Radiosurgery Systems market for the year 2020 and beyond. Radiosurgery Systems utilize beams to deliver a focused dose of radiation to a targeted tumour. Linear Accelerator (LINAC) Radiosurgery Systems and GammaKnife Radiosurgery Systems are tracked under this segment. Rising incidence of cancer is...
-
Product Insights
Likelihood of Approval Analysis for Chemotherapy Induced Nausea and Vomiting
Overview How likely is it that the drugs in Chemotherapy Induced Nausea and Vomiting will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Chemotherapy Induced Nausea and Vomiting Overview Chemotherapy-induced nausea and...
-
Product Insights
Likelihood of Approval Analysis for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)
Overview How likely is it that the drugs in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)...
-
Product Insights
Likelihood of Approval Analysis for Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Overview How likely is it that the drugs in Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)...
-
Product Insights
Likelihood of Approval Analysis for Poisoning
Overview How likely is it that the drugs in Poisoning will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Poisoning Overview A poison refers to any substance harmful to the body, whether...
-
Product Insights
Likelihood of Approval Analysis for Drug Toxicity
Overview How likely is it that the drugs in Drug Toxicity will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Drug Toxicity Overview Drug toxicity' can be defined as a diverse array...
-
Product Insights
Likelihood of Approval Analysis for Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD))
Overview How likely is it that the drugs in Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) Overview Adrenoleukodystrophy is a disorder that...
-
Product Insights
Likelihood of Approval Analysis for Angioedema
Overview How likely is it that the drugs in Angioedema will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Angioedema Overview Angioedema, characterized by non-pitting edema affecting various tissues, can become life-threatening...